CDC launches $25M diabetes screening awareness campaign targeting high-risk communities

What it does

This bill directs the CDC to run a national public awareness campaign about type 1 diabetes screening, targeting both healthcare providers and the public. The campaign will include written materials, public service announcements across media and social platforms, and grants to state and local health departments to increase screening in high-incidence communities. The bill authorizes $5 million per year for five years (2027–2031) and requires a progress report to Congress within one year.

Why we flagged it

The bill's core mechanism is a federally funded public awareness and screening campaign for type 1 diabetes, administered by the CDC through grants and cooperative agreements. It is a straightforward public health initiative with no private carve-outs or regulatory changes.

What the text implies

• Campaign targeting 'communities with largest significant increases in incidence' may concentrate resources on specific geographic regions, potentially creating disparities in awareness and screening access in lower-incidence areas.
• Grants to 'private, nonprofit entities with a history of developing and implementing similar campaigns' may favor established organizations, potentially limiting participation by newer or smaller nonprofits.
• Public service announcements through 'recognized trusted figures' could inadvertently amplify misinformation if those figures lack medical expertise or credibility in diabetes care.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill funds a public health campaign that increases awareness of type 1 diabetes screening and early detection, with targeted outreach to communities experiencing rising incidence. Earlier detection and management of type 1 diabetes reduces serious complications and improves health outcomes for affected individuals and families.

Who stands to gain

• nonprofit organizations (campaign implementation contractors)
• state and local health departments (grant recipients)
• community health centers and primary care providers (recipients of screening resources)

Named in the bill

Centers for Disease Control and Prevention (CDC), Secretary of Health and Human Services, National Academy of Medicine, State, local, and Tribal public health departments, Community health centers, Elementary and secondary schools, Institutions of higher education

Where it stands

3 cosponsors: 2 Democrats, 1 Republicans.

• May 20, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• May 20, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $260,000 in lobbying spend. A filing names 5 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

Jeanne Shaheen, the sponsor, reported $-12,050 in PAC receipts in the 2026 cycle.

• Breakthrough T1d (formerly Known As Jdrf Intl.) — $220,000 on 1 filing
• Revvity, Inc. — $40,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.